Revision: Dec. 4, 2019, 8:15 a.m.
CHAPTER 277
SB 224-FN - FINAL VERSION
03/07/2019 0590s
8May2019... 1673h
2019 SESSION
19-1020
01/10
SENATE BILL 224-FN
AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.
SPONSORS: Sen. Rosenwald, Dist 13; Sen. Fuller Clark, Dist 21; Sen. Hennessey, Dist 5; Sen. Chandley, Dist 11; Sen. Sherman, Dist 24; Rep. Nordgren, Graf. 12; Rep. Marsh, Carr. 8; Rep. Campion, Graf. 12; Rep. Cushing, Rock. 21; Rep. Berrien, Rock. 18
COMMITTEE: Commerce
─────────────────────────────────────────────────────────────────
AMENDED ANALYSIS
This bill clarifies insurance coverage for treatment for pediatric autoimmune neuropsychiatric disorders.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
03/07/2019 0590s
8May2019... 1673h 19-1020
01/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Nineteen
AN ACT relative to insurance coverage for pediatric autoimmune neuropsychiatric disorders.
Be it Enacted by the Senate and House of Representatives in General Court convened:
277:1 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, II to read as follows:
II. Notwithstanding any other provision of law, each insurer that issues or renews any policy of [group] accident or health insurance and each nonprofit health service corporation under RSA 420-A and health maintenance organization under RSA 420-B providing benefits for disease or sickness in the state of New Hampshire shall provide benefits for treatment and diagnosis of certain biologically-based mental illnesses under the same terms and conditions and which are no less extensive than coverage provided for any other type of health care for physical illness.
277:2 Coverage for Certain Biologically-Based Mental Illnesses. Amend RSA 417-E:1, III(f) to read as follows:
(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders, when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician.
277:3 Coverage for Certain Biologically-Based Mental Illnesses. RSA 417-E:1, III(f) is repealed and reenacted to read as follows:
(f) Obsessive-compulsive disorder, including pediatric autoimmune neuropsychiatric disorders.
I. Section 3 of this act shall take effect July 1, 2024.
II. The remainder of this act shall take effect 60 days after its passage.
Approved: July 19, 2019
Effective Date:
I. Section 3 shall take effect July 1, 2024.
II. Remainder shall take effect September 17, 2019.